Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis-Reference-Cited by-同舟云学术

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis

Published:2018-12 Issue:12 Volume:26 Page:2863-2874
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ahn Sang Kyun,Tran Vanessa,Leung Andrea,Ng Mark,Li Ming,Liu Jun

Funder

Canadian Institutes of Health Research

CIHR Frederick Banting and Charles Best Canada Graduate Scholarship

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference86 articles.

1. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature;Colditz;Pediatrics,1995

2. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness;Trunz;Lancet,2006

3. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature;Brewer;Clin. Infect. Dis.,2000

4. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature;Colditz;JAMA,1994

5. Variation in protection by BCG: implications of and for heterologous immunity;Fine;Lancet,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice;Human Vaccines & Immunotherapeutics;2024-01-23

2. Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis;Biomedicines;2022-10-29

3. A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19;Frontiers in Immunology;2022-08-26

4. Recent developments in systems biology and genetic engineering toward design of vaccines for TB;CRIT REV BIOTECHNOL;2022

5. Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis;Vaccines;2022-01-14